429 related articles for article (PubMed ID: 36140271)
1. The Post-Translational Modification Networking in WNK-Centric Hypertension Regulation and Electrolyte Homeostasis.
Lin SC; Ma C; Chang KJ; Cheong HP; Lee MC; Lan YT; Wang CY; Chiou SH; Huo TI; Hsu TK; Tsai PH; Yang YP
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140271
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of regulation of renal ion transport by WNK kinases.
Huang CL; Yang SS; Lin SH
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):519-25. PubMed ID: 18695394
[TBL] [Abstract][Full Text] [Related]
3. Regulatory control of the Na-Cl co-transporter NCC and its therapeutic potential for hypertension.
Meor Azlan NF; Koeners MP; Zhang J
Acta Pharm Sin B; 2021 May; 11(5):1117-1128. PubMed ID: 34094823
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Renal Electrolyte Transport by WNK and SPAK-OSR1 Kinases.
Hadchouel J; Ellison DH; Gamba G
Annu Rev Physiol; 2016; 78():367-89. PubMed ID: 26863326
[TBL] [Abstract][Full Text] [Related]
5. Phosphoregulation of the Na-K-2Cl and K-Cl cotransporters by the WNK kinases.
Kahle KT; Rinehart J; Lifton RP
Biochim Biophys Acta; 2010 Dec; 1802(12):1150-8. PubMed ID: 20637866
[TBL] [Abstract][Full Text] [Related]
6. SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation.
Thastrup JO; Rafiqi FH; Vitari AC; Pozo-Guisado E; Deak M; Mehellou Y; Alessi DR
Biochem J; 2012 Jan; 441(1):325-37. PubMed ID: 22032326
[TBL] [Abstract][Full Text] [Related]
7. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
[TBL] [Abstract][Full Text] [Related]
8. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
9. WNK-SPAK/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension.
Brown A; Meor Azlan NF; Wu Z; Zhang J
Acta Pharmacol Sin; 2021 Apr; 42(4):508-517. PubMed ID: 32724175
[TBL] [Abstract][Full Text] [Related]
10. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
[TBL] [Abstract][Full Text] [Related]
11. The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters.
Alessi DR; Zhang J; Khanna A; Hochdörfer T; Shang Y; Kahle KT
Sci Signal; 2014 Jul; 7(334):re3. PubMed ID: 25028718
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.
Nishida H; Sohara E; Nomura N; Chiga M; Alessi DR; Rai T; Sasaki S; Uchida S
Hypertension; 2012 Oct; 60(4):981-90. PubMed ID: 22949526
[TBL] [Abstract][Full Text] [Related]
13. Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade.
Chiga M; Rafiqi FH; Alessi DR; Sohara E; Ohta A; Rai T; Sasaki S; Uchida S
J Cell Sci; 2011 May; 124(Pt 9):1391-5. PubMed ID: 21486947
[TBL] [Abstract][Full Text] [Related]
14. A minor role of WNK3 in regulating phosphorylation of renal NKCC2 and NCC co-transporters in vivo.
Oi K; Sohara E; Rai T; Misawa M; Chiga M; Alessi DR; Sasaki S; Uchida S
Biol Open; 2012 Feb; 1(2):120-7. PubMed ID: 23213404
[TBL] [Abstract][Full Text] [Related]
15. Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1.
Richardson C; Rafiqi FH; Karlsson HK; Moleleki N; Vandewalle A; Campbell DG; Morrice NA; Alessi DR
J Cell Sci; 2008 Mar; 121(Pt 5):675-84. PubMed ID: 18270262
[TBL] [Abstract][Full Text] [Related]
16. WNK kinases: molecular regulators of integrated epithelial ion transport.
Kahle KT; Wilson FH; Lalioti M; Toka H; Qin H; Lifton RP
Curr Opin Nephrol Hypertens; 2004 Sep; 13(5):557-62. PubMed ID: 15300163
[TBL] [Abstract][Full Text] [Related]
17. WNK lies upstream of kinases involved in regulation of ion transporters.
Gamba G
Biochem J; 2005 Oct; 391(Pt 1):e1-3. PubMed ID: 16173916
[TBL] [Abstract][Full Text] [Related]
18. Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder.
Sohara E; Uchida S
Nephrol Dial Transplant; 2016 Sep; 31(9):1417-24. PubMed ID: 26152401
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological roles of WNK kinases in the kidney.
Uchida S
Pflugers Arch; 2010 Sep; 460(4):695-702. PubMed ID: 20490538
[TBL] [Abstract][Full Text] [Related]
20. Constitutively Active SPAK Causes Hyperkalemia by Activating NCC and Remodeling Distal Tubules.
Grimm PR; Coleman R; Delpire E; Welling PA
J Am Soc Nephrol; 2017 Sep; 28(9):2597-2606. PubMed ID: 28442491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]